Post Marketing Surveillance (PMS) Study of Cresemba in Korea.

Study Summary

The purpose of this study is to observe safety and effectiveness of Cresemba in patients with invasive Aspergillosis or invasive Mucormycosis in Korea during the post-marketing surveillance period as required by Ministry of Food and Drug Safety (MFDS).

Conditions

Aspergillosis Mucormycosis

Interventions / Drugs

Isauvuconazole group

View on ClinicalTrials.gov ↗

Sponsor

Study Details

Enrollment600 participants

Primary Completion—

Lead SponsorPfizer

Data Retrieved2026-04-11 02:55:53.190429+00:00

Not financial advice. BiotechSigns data is sourced from ClinicalTrials.gov, SEC EDGAR, and other public databases for research and informational purposes only. It does not constitute investment recommendations. Always do your own due diligence before making investment decisions.